RBC Bioscience debuts, precision medicine at your service.
RBC Bioscience was established in 2006 and has been focused on the mid-to-upstream nucleic acid purification market in precision medicine since its inception. 
With over a decade of experience in nucleic acid extraction, our company has developed the brand "MagCore" covering reagent manufacturing, magnetic bead development, production, marketing, and automation equipment. 
Previously concentrating on overseas markets, the products have been sold in more than 60 countries worldwide. 
In recent years, RBC has expanded its OEM manufacturing and sales.
Our company previously emphasized promotion in the European and American markets, and now we're making the first appearance at The Bio Asia Taiwan 2024. 
In addition to our brand, the company is now actively focusing on cancer detection and has started to represent related well-known foreign brands. 
The aim is to provide people with better choices in medical quality and to achieve higher sales performance in the post-pandemic era.

Looking forward to meet you at hall 1 booth M509 on 25-28 July 2024.